World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
30060
World Ranking
11764
National Ranking
6032

Overview

Edward M. Messing is affiliated with the University of Rochester Medical Center in the United States. Their research primarily focuses on the medical field, with a significant concentration on surgery and pulmonary and respiratory medicine. Additional subfields of study include molecular biology, oncology, and urology.

The scientist's work extensively covers topics related to bladder and urothelial cancer treatments, urinary and genital oncology studies, and prostate cancer research, both in treatment and diagnosis. Renal cell carcinoma treatment, esophageal cancer research and treatment, and extracellular vesicles in disease are also among the key areas of study.

Frequent coauthors include Jean Joseph, Shuyuan Yeh, Yi-Fen Lee, Chawnshang Chang, and Christopher Silvers. These collaborations have contributed to a range of publications and research developments within the fields of urology and oncology.

Edward M. Messing publishes regularly in a selection of journals, with the most frequent venues being The Journal of Urology, Bladder Cancer, Urologic Oncology Seminars and Original Investigations, Urology Practice, and European Urology.

Notable recent papers include:

  • "Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma" (2021) published in European Urology
  • "The androgen receptor in bladder cancer" (2023) published in Nature Reviews Urology
  • "Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study" (2023) published in The Journal of Urology
  • "Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer" (2021) published in British Journal of Cancer
  • "Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members" (2020) published in Urologic Oncology Seminars and Original Investigations

Best Publications

  • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

    E M Messing;J Manola;M Sarosdy;G Wilding

  • Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    Edward M Messing;Judith Manola;Jorge Yao;Maureen Kiernan

  • Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

    Emil Scosyrev;Edward M. Messing;Richard Sylvester;Steven Campbell

  • Interstitial cystitis: early diagnosis, pathology, and treatment.

    Edward M. Messing;Thomas A. Stamey

  • Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline

    Rodney Davis;J. Stephen Jones;Daniel A. Barocas;Erik P. Castle

  • Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Vinata B. Lokeshwar;Tomonori Habuchi;H. Barton Grossman;William M. Murphy

  • Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

    Mark S. Soloway;Joseph V. Briggman;Gennaro A. Carpinito;Gerald W. Chodak

  • Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

    Hiroshi Miyamoto;Zhiming Yang;Yei Tsung Chen;Hitoshi Ishiguro

  • Detection of bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Edward Messing;Mark Soloway;Kevin Tomera

  • Androgen deprivation therapy for prostate cancer: current status and future prospects.

    Hiroshi Miyamoto;Edward M. Messing;Chawnshang Chang;Chawnshang Chang

  • Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial

    Edward M. Messing;Judith Manola;George Wilding;Kathleen Propert

  • Sex and racial differences in bladder cancer presentation and mortality in the US

    Emil Scosyrev;Katia Noyes;Changyong Feng;Edward Messing

  • A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis

    G.R. Sant;K.J. Propert;P.M. Hanno;D. Burks

  • Androgen receptor is a tumor suppressor and proliferator in prostate cancer

    Yuanjie Niu;Saleh Altuwaijri;Kuo-Pao Lai;Chun-Te Wu

  • Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

    Gregory P. Swanson;Michael A. Hussey;Catherine M. Tangen;Joseph Chin

  • Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.

    Edward M. Messing;Edward M. Messing;Theresa B. Young;Vernon B. Hunt;Kennedy W. Gilchrist

  • Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Mark Soloway;Edward Messing;Giora Katz

  • Is there a favorable subset of patients with prostate cancer who develop oligometastases

    Deepinder Singh;Won Sam Yi;Ralph A Brasacchio;Ann G Muhs

Frequent Co-Authors

Chawnshang Chang
Chawnshang Chang University of Rochester Medical Center
Shuyuan Yeh
Shuyuan Yeh University of Rochester Medical Center
Supriya G. Mohile
Supriya G. Mohile University of Rochester Medical Center
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Catherine M. Tangen
Catherine M. Tangen Fred Hutchinson Cancer Research Center
George Wilding
George Wilding University of Wisconsin–Madison
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
E. David Crawford
E. David Crawford University of California, San Diego
Donald L. Trump
Donald L. Trump University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA is diverse, with several related degrees and pathways available online. Many students interested in healthcare leadership can consider cahme-accredited online mha programs, which prepare graduates for management roles in hospitals and other clinical settings.

Registered Nurses looking to upskill can explore flexible options like the rn to bsn without clinicals pathway. This allows working RNs to advance their education without the need for additional in-person clinical hours, making it accessible for busy professionals.

For those aiming for advanced clinical or academic positions, the shortest dnp programs offer a fast track to a Doctor of Nursing Practice degree. These programs are designed for efficiency while maintaining academic rigor.

Affordability remains a concern for many students; fortunately, some of the cheapest dnp program options can help reduce the financial burden of advanced nursing education, making career progression possible for a wider range of students.

Best Scientists Citing Edward M. Messing

Trending Scientists